NovoCure Limited

In 2000, Yoram Palti, our founder and professor emeritus of physiology and biophysics at the Technion — Israel Institute of Technology, sought to leverage his expertise in biophysics to develop a new way to treat solid tumor cancers that would destroy tumor cells while sparing healthy tissue and avoiding many of the life-altering side effects of existing cancer therapies.He set up a laboratory in his basement to explore the potential of electric fields as a treatment for solid tumors.

 

Bank Name NovoCure Limited
Stock Exchange NASDAQ
Symbol NVCR
Sector Healthcare
Industry Medical/Dental Instruments
Country United States
World Region Amarica
Chairman Mr. William F. Doyle
CEO Mr. Asaf Danziger
Employees 495
Website www.novocure.com
Registered Year 2000

 

UpdateContent
UpdateContent
UpdateContent